Fluorine-containing compounds exhibit unique physicochemical properties and, consequently, they are of interest in medicinal chemistry, crop protection, and material sciences. 1 In this context, the pentafluorosulfanyl group (SF 5 ), also known as 'super-trifluoromethyl' group, plays a very special role. 1, 2 Noteworthy are, for example, the high thermal stability of aryl sulfurpentafluorides and the chemical inertness of the SF 5 group towards hydrolysis. 3 Compared with a trifluoromethyl substituent, the SF 5 group has a higher electronegativity 4 and polarity, and the respective molecules show improved lipophilicity. 5 As a result, the SF 5 group has become an attractive structural motif in the design of biologically active compounds, 2b,c,6 functional materials, 7 and, as recently reported, in Brønsted acid catalysts. 8 Due to the fact that only a few efficient synthetic methods for the introduction of the SF 5 group exist, 3, 9 commercially available SF 5 -containing building blocks are rare and most of them are expensive. Therefore, the development of new scaffolds with SF 5 groups appears to be desirable.
Sulfoximines, the mono-aza analogues of sulfones, are widely used in asymmetric synthesis and catalysis. 10 Especially in the last years, such compounds have also attracted attention as drugs 11 and crop protection agents. 12 Advantageously, in contrast to sulfones, they are modifiable at the sulfoximine nitrogen, which can lead to beneficial effects on the solubility of the respective molecules.
13 Fluorinecontaining sulfoximines 11, 12, [14] [15] [16] are of particular interest because they combine the advantages of the sulfoximidoyl moiety with the favorable electronic and steric properties induced by, for example, a fluoro or a trifluoromethyl substituent. However, to our knowledge, sulfoximines bearing SF 5 groups are unprecedented. Here, we fill this synthetic gap and report on preparative routes towards a range of key compounds with sulfoximidoyl cores and SF 5 substituents.
For the preparation of the first target molecule (NHsulfoximine 4), methyl 4-pentafluorosulfanylphenyl sulfide (1) was regarded as a promising starting material. 17 Fulfilling our expectations, the imination of 1 with cyanamide and N-bromosuccinimide (NBS) 18 proceeded smoothly, affording the corresponding N-cyano sulfilimine 2 in 96% yield (Scheme 1). Subsequent oxidation with m-CPBA 18 led to N-cyano sulfoximine 3 in 81% yield. Finally, the CN-group was cleaved upon treatment with 50% aq. H 2 SO 4 at 110 °C, 19 providing the desired NH-sulfoximine 4 in 71% yield. 20 Both enantiomers of the racemic mixture could be separated on analytical CSP HPLC, which allowed 4 to be obtained in non-racemic form by preparative HPLC separation. Considering that N-arylated sulfoximines can be highly selective ligands in asymmetric metal catalysis, 10, 22 we first investigated the application of a representative N-phenylation protocol allowing the conversion of 4-pentafluorosulfanylphenyl sulfoximine (4) into N-arylated sulfoximine 5 under copper catalysis. 23 To our delight, this approach was 
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highly efficient, providing N-phenyl sulfoximine 5 in 93% yield starting from 4 and iodobenzene as aryl source (Scheme 2).
Scheme 2 Derivatizations of NH-sulfoximine 4 and conversion of N-cyano sulfoximine 3
We then focused on the N-methylation of 4 to give 6. This transformation was regarded as particularly important because it was recently demonstrated that several N-methyl sulfoximines showed a significantly higher solubility compared with their isolipophilic counterparts in the sulfone series, 13a leading to beneficial effects in their respective bioactivity studies. Here, the N-methylation of 4 was successfully performed under Eschweiler-Clark conditions, 24, 25 affording N-methylated sulfoximine 6 in 78% yield (Scheme 2).
Considering that tetrazoles are carboxylic acid bioisosteres that often exhibit high bioactivities, 26 the conversion of N-cyano sulfoximine 3 into tetrazole 7 was studied. 27 By using a combination of NaN 3 and ZnBr 2 in methanolwater, formation of the heterocycle proceeded smoothly, leading to N-(1H)-tetrazole methyl 4-pentafluorosulfanylphenyl sulfoximine (7) in 62% yield (Scheme 2).
The three representative synthetic transformations depicted in Scheme 2 allow us to draw two significant conclusions: first, compounds such as 4 are readily available; and second, standard protocols can be used for modifications of sulfoximines with 4-pentafluorosulfanyl substituents providing interesting new building blocks for future synthetic and biological applications.
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